81.9 F
Key West
Tuesday, July 16, 2019
Home RESEARCH REPORTS

RESEARCH REPORTS

Are Insiders Buying or Selling? Or Just Smoking Weed & Blowing it up your..

“Overall, we are beginning to see massive amounts of insider buying taking place in microcap names that have been decimated during the current market downturn. ” GEOInvesting

Crop Corp, (CRXPF) All Signs Poised to Massive Revenue Gains in 2019. Report Update...

Like a Wind Tunnel at Their Back. A lot of unexpected things can go wrong during the planting stage with Growers which can keep less venturesome investors on the...

Biome Grow (BIO.C and BIOIF) Up 25%, New Report Out (MarijuanaStockReview)

Up 25% 12/17/18 With Dow Down 500 Points! Gains 25% With Major Win Under Health Canada Act.    Upgraded License From Health Canada Completes...

Biome Grow (BIO.C) Signs Massive Provincial Supply Agreement. (CFN Media).

SEATTLE, Dec. 07, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of...

Cronos Target $3.50 ? (CitronResearch).

(Note, this was written before Cronos confirmed that it is engaged in discussions concerning a potential investment by Altria Group Inc. (MO) ("Altria Group") in Cronos Group. No agreement has been reached with respect to...

Some of Our Favorite Beverage Names, Including CBD Beverages.

We've done swimmingly well with some older names which announced a line extension to include CBD infused offerings. So we are putting together a beverage sub-sector list together that includes names we figure to...

Medmen (MMNFF) $3.60: Potential, But Some Major Concerns (SeekingAlpha)

Summary Medmen has been in business as a retailer for a few years however has not achieved profitability. After what could only be labelled a dizzying pace, the company has acquired multiple companies.  They...
$NXEN, nxen

Nexien (NXEN) Bolsters Management Roster with CRx Bio Acquisition (OwnTheFloat).

Nexien BioPharma is a US-based pharmaceutical company engaged in the formulation, development and commercialization of cannabinoid-based pharmaceuticals in accordance with U.S. Food and Drug Administration ("FDA") pre-clinical and clinical pathways, to address a broad...

Marijuana Stock Review Initiates Coverage On Biome Growers Inc. (BIO)

$210 Million in Identifiable Growth Properties. The Next Big Canadian Cannabis Conglomerate? We are adding Biome Grow Inc (CSE: BIO) to the Watch List which began trading today @$1.49 CDN. We are excited to add them...
Crop Corp

Crop Corp (CRXPF) Chart-O-the-Day.

Not much to say other than woo-hoo! Symbol CROP and CRXPF. Click here for report.